This report contains market size and forecasts of Tenofovir/Alafenamide Compound Drugs in global, including the following market information:
Global Tenofovir/Alafenamide Compound Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Tenofovir/Alafenamide Compound Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Tenofovir/Alafenamide Compound Drugs companies in 2021 (%)
The global Tenofovir/Alafenamide Compound Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Bottled Packaging Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Tenofovir/Alafenamide Compound Drugs include Gilead Sciences, Cipla, Mylan Pharmaceuticals, Natco Pharma, Sun Pharmaceutical Industries, Beacon Pharmaceuticals and Julphar Bangladesh, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tenofovir/Alafenamide Compound Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Tenofovir/Alafenamide Compound Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir/Alafenamide Compound Drugs Market Segment Percentages, by Type, 2021 (%)
Bottled Packaging
Film Coated Packaging
Global Tenofovir/Alafenamide Compound Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir/Alafenamide Compound Drugs Market Segment Percentages, by Application, 2021 (%)
Chronic Hepatitis (HBV) in Adults
Chronic Hepatitis (HBV) in Children over 12 Years Old
Global Tenofovir/Alafenamide Compound Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Tenofovir/Alafenamide Compound Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Tenofovir/Alafenamide Compound Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Tenofovir/Alafenamide Compound Drugs revenues share in global market, 2021 (%)
Key companies Tenofovir/Alafenamide Compound Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Tenofovir/Alafenamide Compound Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Gilead Sciences
Cipla
Mylan Pharmaceuticals
Natco Pharma
Sun Pharmaceutical Industries
Beacon Pharmaceuticals
Julphar Bangladesh